FOR the first time in the UK expert doctors will be able to prescribe cannabis-based medicines for patients which could benefit from the treatments.
The law change comes after Home Secretary and Bromsgrove MP Sajid Javid, listened to concerns from parents of children with conditions such as severe epilepsy.
Over the summer he called for an urgent review of cannabis-based medicinal products and agreed with recommendations from the Advisory Council on the Misuse of Drugs (ACMD) and the UK’s Chief Medical Adviser.
The new law will not limit the types of conditions that can be considered for treatment and doctors will no longer need to seek approval from an expert panel in order for patients to access the medicines.
Earlier this year, Mr Javid intervened in the cases of Alfie Dingley and Billey Caldwell.
Alfie’s family had been campaigning for the six-year-old to legally receive cannabis oil to treat his rare form of epilepsy and Mr Javid granted him the first ever permanent medical cannabis licence.
Prior to that 12-year-old Billy was granted a limited licence for a 20-day supply of medical cannabis, also to treat severe epilepsy.
Mr Javid said: “Having been moved by heartbreaking cases involving sick children, it was important to me that we took swift action to help those who can benefit from medicinal cannabis.
“We have now delivered on our promise and specialist doctors will have the option to prescribe these products where there is a real need.
“I’m grateful to the expert panel – who have been considering cases in the interim – and to those who’ve worked hard to bring about this change at the earliest possible opportunity.”
The decision must be taken to prescribe the unlicensed medicines must be made by a specialist doctor not a GP.
The designated doctors focus on one field of medicine such as neurology or paediatrics and are listed on the General Medical Council’s specialist register.
They must make decisions on prescribing cannabis-based products for medicinal use on a case-by-case basis, and only when the patient has an unmet special clinical need that cannot be met by licensed products.
Patients under the care of a specialist should discuss their treatment plan with them.
NHS England, the British Paediatric Neurology Association and the Royal College of Physicians will provide clinical advice to doctors ahead of the law change.
The National Institute for Health and Care Excellence has been commissioned to develop more detailed guidelines for clinicians in the longer term.
President of the Royal Pharmaceutical Society, Professor Ashok Soni OBE, said the news would be welcomed by many patients with serious health conditions.
“The prospect of a future where safe and effective licensed cannabis-based medicines can be prescribed to help relieve suffering is genuinely exciting.”
We will work with the NHS to help support specialists in making the right prescribing decisions.
The Home Secretary has made it clear that today’s announcement does not pave the way towards legalising cannabis for recreational use. The penalties for unauthorised supply and possession will remain unchanged.